{"id":392291,"date":"2020-12-02T21:03:17","date_gmt":"2020-12-03T02:03:17","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=392291"},"modified":"2020-12-02T21:03:17","modified_gmt":"2020-12-03T02:03:17","slug":"bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/","title":{"rendered":"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Dec.  02, 2020  (GLOBE NEWSWIRE) &#8212; Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen, Inc. (NASDAQ: BIIB), JOYY, Inc. (NASDAQ: YY), Berry Corporation (NASDAQ: BRY), and Pinterest, Inc. (NYSE: PINS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.<\/p>\n<p align=\"justify\">\n        <strong>Biogen, Inc. (NASDAQ: BIIB)<\/strong>\n      <\/p>\n<p align=\"justify\">Class Period: October 22, 2019 to November 6, 2020<\/p>\n<p align=\"justify\">Lead Plaintiff Deadline: January 12, 2021<\/p>\n<p align=\"justify\">On November 6, 2020, Reuters published an article entitled \u201cFDA advisory panel convenes to discuss whether Biogen Alzheimer&#8217;s drug should be approved\u201d which stated that \u201cBiogen shares were halted ahead of the advisory panel meeting.\u201d Later on November 6, 2020, Reuters published an article entitled \u201cU.S. FDA panel votes cannot ignore unsuccessful trial data on Biogen Alzheimer&#8217;s drug.\u201d<\/p>\n<p align=\"justify\">On this news, Biogen\u2019s stock price fell $92.64 per share, or 28%, to close at $236.26 per share on November 9, 2020, the next trading day.<\/p>\n<p align=\"justify\">The complaint, filed on November 13, 2020, alleges that throughout the Class Period defendants made false and\/or misleading statements and\/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab\u2019s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding aducanumab\u2019s effectiveness; (3) the PRIME study did not and would not provide necessary data regarding aducanumab\u2019s effectiveness; (4) the data provided by the Company to the FDA\u2019s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, defendants\u2019 statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n<p align=\"justify\">For more information on the Biogen securities class action case go to: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o53meDgCQAaIy1JGmF1X0_mfXkjt0_-GWUpvIFPImXceNqcdMKVhphQ5u7h_lyNwul59X7DpmcohClsJno98maMjYoef0k6EF8sR0_E-A9c=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/bespc.com\/cases\/BIIB<\/a><\/p>\n<p align=\"justify\">\n        <strong>JOYY, Inc. (NASDAQ: YY)<\/strong>\n      <\/p>\n<p align=\"justify\">Class Period: April 28, 2016 to November 18, 2020<\/p>\n<p align=\"justify\">Lead Plaintiff Deadline: January 19, 2021<\/p>\n<p align=\"justify\">On November 18, 2020, while the market was open, Muddy Waters Research published a report alleging that JOYY, among other things, had: (i) reported fraudulent revenue; (ii) component businesses that were a fraction of the size that it reports; and (iii) acquired BIGO as part of a scam that benefitted corporate insiders.<\/p>\n<p align=\"justify\">On this news, JOYY\u2019s ADRs fell $26.53 per share, or 26.4%, to close at $73.66 per share on November 18, 2020.<\/p>\n<p align=\"justify\">The complaint, filed on November 20, 2020, alleges that defendants made false and\/or misleading statements and\/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) the majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company\u2019s acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, defendants\u2019 public statements were materially false and\/or misleading at all relevant times.<\/p>\n<p align=\"justify\">For more information on the JOYY class action go to: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o53meDgCQAaIy1JGmF1X0_mfXkjt0_-GWUpvIFPImXcWwyR8AFzM30XIa2UePJdLHPSKyTLIEJXnd7MSS4wP3ErHLmOepTagD6sTPbU3WwE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/bespc.com\/cases\/YY<\/a><\/p>\n<p align=\"justify\">\n        <strong>Berry Corporation (NASDAQ: BRY)<\/strong>\n      <\/p>\n<p align=\"justify\">Class Period: (a) Common stock purchased pursuant and\/or traceable to the Company\u2019s initial public offering conducted on or about July 26, 2018 (the \u201cIPO\u201d or \u201cOffering\u201d); or (b) Berry securities purchased between July 26, 2018 and November 3, 2020 (the \u201cClass Period\u201d).<\/p>\n<p align=\"justify\">Lead Plaintiff Deadline: January 21, 2021<\/p>\n<p align=\"justify\">On\u00a0June 29, 2018, the Company filed its Registration Statement on Form S-l for the IPO, which, after an amendment, was declared effective by the SEC on\u00a0July 25, 2018\u00a0(the \u201cRegistration Statement\u201d). On or around\u00a0July 26, 2018, Berry conducted the IPO, upon which the Company began trading on the NASDAQ Global Select market (\u201cNASDAQ\u201d), issuing 13 million shares of Berry common stock at\u00a0$14\u00a0per share, generating over\u00a0$138 million\u00a0in proceeds before expenses. On\u00a0July 27, 2018\u00a0Berry filed its Prospectus on Form 424B4 with the SEC (the \u201cProspectus\u201d and, collectively with the Registration Statement, the \u201cOffering Documents\u201d).<\/p>\n<p align=\"justify\">On November 3, 2020, Berry reported its financial and operating results for the third quarter of 2020. Among other results, Berry reported non-GAAP EPS and revenue that both fell short of estimates. In addition, Berry reported that during the quarter, \u201cthe Company undertook certain operational improvements that caused temporary reductions in our production. Notably, we performed some plugging and abandonment activity that resulted in the temporary shut-in of nearby wells. Additionally, improved steam management reduced overall costs but temporarily increased water disposal and well maintenance needs, resulting in a slight decrease in production.\u201d<\/p>\n<p align=\"justify\">On this news, the Company\u2019s stock price fell $0.15 per share, or 5.28%, to close at $2.69 per share on November 4, 2020, representing an 80.78% decline from the IPO price.<\/p>\n<p align=\"justify\">The complaint, filed on November 20, 2020, alleges that the Offering Documents were negligently prepared, and, as a result, contained untrue statements of material fact, omitted material facts necessary to make the statements contained therein not misleading, and failed to make necessary disclosures required under the rules and regulations governing their preparation. Additionally, throughout the Class Period, defendants made materially false and misleading statements regarding the Company\u2019s business, operational and compliance policies. Specifically, the Offering Documents and defendants made false and\/or misleading statements and\/or failed to disclose that: (i) Berry had materially overstated its operational efficiency and stability; (ii) Berry\u2019s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company\u2019s productivity and increase costs; (iii) the foregoing would foreseeably negatively impact the Company&#8217;s revenues; and (iv) as a result, the Offering Documents and the Company\u2019s public statements were materially false and\/or misleading and failed to state information required to be stated therein.<\/p>\n<p align=\"justify\">For more information on the Berry Corporation class action go to: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o53meDgCQAaIy1JGmF1X0_mfXkjt0_-GWUpvIFPImXfsp1vB8sGED6pS8sAPBUwE504UAFstOzT2dOk9kGOjNyYKMTF021DN693dBMFSBsw=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/bespc.com\/cases\/BRY<\/a><\/p>\n<p align=\"justify\">\n        <strong>Pinterest, Inc. (NYSE: PINS)<\/strong>\n      <\/p>\n<p align=\"justify\">Class Period: May 16, 2019 to November 1, 2019<\/p>\n<p align=\"justify\">Lead Plaintiff Deadline: January 22, 2021<\/p>\n<p align=\"justify\">On October 31, 2019, the Company announced its financial results for the quarter ended September 30, 2019. The Company reported disappointing financial results, including 8% growth in the U.S. MAUs year over year, reaching 87 million, only 8 million more than the same period of the previous year. Pinterest also missed its consensus projections and reported lower than expected U.S. advertising revenue. The Company only marginally increased its full year 2019 guidance, implying further deceleration in the future quarters.<\/p>\n<p align=\"justify\">On this news, the price of the Company\u2019s shares steeply declined by 17%, to close at $20.86 on November 1, 2019.<\/p>\n<p align=\"justify\">The Complaint, filed on November 23, 2020, alleges that Pinterest made false and misleading statements to the public throughout the Class Period and failed to disclose that: (i) the Company\u2019s addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest\u2019s future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, defendants\u2019 public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.<\/p>\n<p align=\"justify\">For more information on the Pinterest class action go to: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o53meDgCQAaIy1JGmF1X0_mfXkjt0_-GWUpvIFPImXdXZLQDmMvLvVkmV-CaSkI3fAcr7xBFp0HsqbWfcHbvGe2UvRSyOQybFyKF8YkzltA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/bespc.com\/cases\/PINS<\/a><\/p>\n<p align=\"justify\">\n        <strong>About <\/strong><br \/>\n        <strong>Bragar<\/strong><br \/>\n        <strong>Eagel<\/strong><br \/>\n        <strong> &amp; Squire, P.C.:<\/strong><br \/>\n        <br \/>Bragar Eagel &amp; Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zyl5yB6U707vmPwA0ZE2I_zwrrtl1VyABHDhntMmJ7DzJYiUEWk72-fNrt31uor8GyKXnV5ZUjYcLZVGQzzTaQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.bespc.com<\/u><\/a>. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p align=\"justify\">\n        <strong>Contact Information:<\/strong><br \/>\n        <br \/>Bragar Eagel &amp; Squire, P.C.<br \/>Brandon Walker, Esq. <br \/>Melissa Fortunato, Esq.<br \/>Marion Passmore, Esq.<br \/>(212) 355-4648<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tGNCDbz_2xio8kTFb45TWcsjJLRtLnUhDb_w0LFEa0v5n_Osrf0GtjcuXWqYHJzKyXS7-24xfeGCv8jLf0wK8QpaVHQvkITrruM40v93J98=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>investigations@bespc.com<\/u><\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zyl5yB6U707vmPwA0ZE2I-8KTQDdxR3mW-1uCmK71Rvy3Srzbjg0ONVPfW1_Qnlzt3TCJ7yrp7FHYsqcGT1fyA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.bespc.com<\/u><\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/42ac8e4f-dcc5-4964-868a-3344261145ae\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen, Inc. (NASDAQ: BIIB), JOYY, Inc. (NASDAQ: YY), Berry Corporation (NASDAQ: BRY), and Pinterest, Inc. (NYSE: PINS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Biogen, Inc. (NASDAQ: BIIB) Class Period: October 22, 2019 to November 6, 2020 Lead Plaintiff Deadline: January 12, 2021 On November 6, 2020, Reuters published an article entitled \u201cFDA advisory panel convenes to discuss whether Biogen Alzheimer&#8217;s drug should be approved\u201d which stated &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-392291","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen, Inc. (NASDAQ: BIIB), JOYY, Inc. (NASDAQ: YY), Berry Corporation (NASDAQ: BRY), and Pinterest, Inc. (NYSE: PINS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Biogen, Inc. (NASDAQ: BIIB) Class Period: October 22, 2019 to November 6, 2020 Lead Plaintiff Deadline: January 12, 2021 On November 6, 2020, Reuters published an article entitled \u201cFDA advisory panel convenes to discuss whether Biogen Alzheimer&#8217;s drug should be approved\u201d which stated &hellip; Continue reading &quot;Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-03T02:03:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm\",\"datePublished\":\"2020-12-03T02:03:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/\"},\"wordCount\":1266,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/\",\"name\":\"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=\",\"datePublished\":\"2020-12-03T02:03:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm - Market Newsdesk","og_description":"NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen, Inc. (NASDAQ: BIIB), JOYY, Inc. (NASDAQ: YY), Berry Corporation (NASDAQ: BRY), and Pinterest, Inc. (NYSE: PINS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Biogen, Inc. (NASDAQ: BIIB) Class Period: October 22, 2019 to November 6, 2020 Lead Plaintiff Deadline: January 12, 2021 On November 6, 2020, Reuters published an article entitled \u201cFDA advisory panel convenes to discuss whether Biogen Alzheimer&#8217;s drug should be approved\u201d which stated &hellip; Continue reading \"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-03T02:03:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm","datePublished":"2020-12-03T02:03:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/"},"wordCount":1266,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/","name":"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=","datePublished":"2020-12-03T02:03:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTY4NCMzODUzMzU3IzIxMDAzOTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-biogen-joyy-berry-corporation-and-pinterest-and-encourages-investors-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bragar Eagel &amp; Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/392291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=392291"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/392291\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=392291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=392291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=392291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}